blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0832653

EP0832653 - Use of cytokines and cytotoxic compounds in a method for treatment of tumours [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.07.1999
Database last updated on 24.08.2024
Most recent event   Tooltip27.08.1999Change - German titlepublished on 13.10.1999 [1999/41]
Applicant(s)For all designated states
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
Robert-Rössle-Strasse 10
13125 Berlin / DE
[N/P]
Former [1998/14]For all designated states
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
Robert-Rössle-Str. 10
D-13125 Berlin / DE
Inventor(s)01 / Stein, Ulrike, Dr.
Theodor-Brugsch-Str. 36
13125 Berlin / DE
02 / Walther, Wolgang, Dr.
Theodor-Brugsch-Str. 36
13125 Berlin / DE
03 / Schlag, Peter M., Prof. Dr.
Frohnauer Str. 17a
13467 Berlin / DE
[1998/14]
Representative(s)Baumbach, Friedrich
Patentanwalt
Robert-Rössle-Strasse 10
13125 Berlin / DE
[N/P]
Former [1998/14]Baumbach, Friedrich
BioTeZ Berlin-Buch GmbH Patentstelle Robert-Rössle-Strasse 10
13125 Berlin / DE
Application number, filing date96250206.820.09.1996
[1998/14]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0832653
Date:01.04.1998
Language:DE
[1998/14]
Search report(s)(Supplementary) European search report - dispatched on:EP25.04.1997
ClassificationIPC:A61K38/20, A61K38/19, // A61K31/00
[1998/14]
CPC:
A61K38/191 (EP,US); A61K38/2013 (EP,US); A61P35/00 (EP)
Designated contracting states(deleted) [1998/51]
Former [1998/14]AT,  BE,  CH,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  NL,  PT,  SE 
TitleGerman:Verwendung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung[1999/41]
English:Use of cytokines and cytotoxic compounds in a method for treatment of tumours[1998/14]
French:Utilisation de cytokines en de composés cytotoxiques dans une méthode de traitement des tumeurs[1998/14]
Former [1998/14]Verwenddung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung
Examination procedure02.10.1998Application deemed to be withdrawn, date of legal effect  [1999/37]
22.02.1999Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [1999/37]
Fees paidPenalty fee
Penalty fee Rule 85a EPC 1973
03.12.1998AT   M01   Not yet paid
03.12.1998BE   M01   Not yet paid
03.12.1998CH   M01   Not yet paid
03.12.1998DE   M01   Not yet paid
03.12.1998DK   M01   Not yet paid
03.12.1998ES   M01   Not yet paid
03.12.1998FI   M01   Not yet paid
03.12.1998FR   M01   Not yet paid
03.12.1998GB   M01   Not yet paid
03.12.1998GR   M01   Not yet paid
03.12.1998IE   M01   Not yet paid
03.12.1998IT   M01   Not yet paid
03.12.1998LU   M01   Not yet paid
03.12.1998NL   M01   Not yet paid
03.12.1998PT   M01   Not yet paid
03.12.1998SE   M01   Not yet paid
Penalty fee Rule 85b EPC 1973
03.12.1998M01   Not yet paid
Additional fee for renewal fee
30.09.199803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9601121  (GENENTECH INC [US]) [X] 1-10 * the whole document *;
 [X]  - HO R. ET AL., "Development of Safe and Effective Adriamycin Plus Inteleukin 2 Therapy Against Both Adriamycin-Sensitive and -Resistant Lymphomas", ONCOLOGY RESEARCH, (1993), vol. 5, no. 9, pages 373 - 381, XP000645160 [X] 1-10 * the whole document *
 [X]  - NABIOULLIN R ET AL, "Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.", JAPANESE JOURNAL OF CLINICAL ONCOLOGY 25 (4). 1995. 124-130, XP000645157 [X] 1-10 * the whole document *
 [X]  - REGENASS U. ET AL., "TNF in combination with cytostatic agents", EXPERIENTIA, (1986), vol. 42, no. 6, page 701, XP002026299 [X] 1-10 * the whole document *
 [DX]  - WALTHER W ET AL, "Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: Increased cytotoxicity of MDR relevant drugs.", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 120 (8). 1994. 471-478, XP000645076 [DX] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1007/BF01191800
 [DX]  - WALTHER W ET AL, "Gene transfer of human TNF-alpha into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity.", INTERNATIONAL JOURNAL OF CANCER 61 (6). 1995. 832-839, XP000645062 [DX] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.2910610615
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.